Reduction in number of men screened for and diagnosed with prostate cancer

In the United States, the rate of prostate cancer screening is down, and the number of men diagnosed with the disease has also dropped.

Active surveillance 
encouraged for prostate cancer screening

Men should regularly be screened for prostate cancer, the leading cause of cancer death for men in the United States.

More radiation does not increase survival in low-risk prostate cancer

Higher doses of radiation does not increase survival rates in low-risk prostate cancer.

Radiation, hormone therapy for prostate cancer

Combination radiation and hormone therapy is more effective than hormone therapy alone for the treatment of prostate cancer.

Primary care after PCa

PCPs should encourage physical activity, smoking cessation, and a healthy diet for PCa survivors.

New imaging methods better for prostate CA detection

Multiparametric magnetic resonance imaging reported high accuracy in diagnosing low-risk prostate cancers.

Prostate cancer care measures vary by region

Low adherence rates for prostate cancer care may be target for future quality improvements.

Prostatectomy cuts mortality in early prostate CA

Risk of long-term mortality is lower compared with watchful waiting.

Melatonin linked to lower prostate CA risk

Risk for advanced prostate cancer was 75% lower in men with high levels of 6-sulfatoxymelatonin -- a measure of melatonin breakdown in urine.

Baseline inflammation lowers prostate cancer risk on repeat biopsy

Even after adjustment, acute, chronic inflammation linked to lower PCa risk at two-year repeat biopsy.

Prostate biopsy causes anxiety even when negative

Potential psychological harm associated with biopsy even in absence of cancer diagnosis

Coffee protective against prostate CA recurrence

Drinking coffee may lower the risk for prostate cancer recurrence and disease progression.

Men don't rely on prostate-screen decision aids

Aids help men make more informed choices regarding PSA screening, but did not affect actual screening rates.

Soy not protective against prostate CA recurrence

Men consuming a soy supplement on a daily basis saw no reduction in their chances of prostate cancer recurrence.

Consuming more vegetable fat may cut prostate cancer mortality

Replacing carbohydrates and animal fat with vegetable fat may reduce prostate cancer mortality.

FDA approves Xofigo for advanced prostate cancer

Xofigo has been approved three months ahead of schedule to treat men with metastatic castration-resistant prostate cancer.

Exercise cuts prostate cancer risk in whites

Regular, moderate exercise was associated with decreased prostate cancer risk in white, but not black, men.

FDA approves Zytiga for advanced prostate cancer

The FDA has expanded the indication for abiraterone acetate to include treating late-stage castration-resistant prostate cancer before the administration of chemotherapy.

FDA approves prostate cancer imaging agent

Choline C 11 Injection, a PET scan imaging agent, is now available for men with elevated PSA levels after earlier treatment for prostate cancer.

Cancer survivors uneasy with primary care follow-up

Lack of cancer expertise, continuity of care cited as barriers to receiving follow-up cancer care from primary care providers.

FDA approves new test for prostate cancer

The Prostate Health Index is a non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than prostate-specific antigen in patients with PSA values in the 4-10 ng/mL range.

USPSTF recommends against PSA-based screening

Based on the evidence, the U.S. Preventive Services Task Force gave a grade D recommendation against PSA-based screening for men in the general U.S. population, regardless of age.

Uncertainty common when deciding to stop PSA screening

Many clinicians find it difficult to determine when it's appropriate to stop screening patients for prostate cancer.

Jury still out on value of PSA screening

Extended follow-up data from the European Randomized Study of Screening for Prostate Cancer shows screening reduced risk of death from prostate cancer, but not all-cause mortality.

Vitamin E may hurt prostate and saw palmetto doesn't help

Two studies offer data about the effects if vitamin E and saw palmetto on the prostate.

Coffee consumption decreased risk for lethal prostate cancer

Drinking one to three cups of coffee a day was associated with a 30% lower risk of lethal prostate cancer.

Mortality unaffected by prostate screening

A 20-year study has revealed that the rate of death from prostate cancer did not differ significantly between men who had been screened for the disease and men who had not.

Primary care providers ordering more PSA tests

U.S. primary care providers ordered twice as many office-based prostate-specific antigen tests in 2008 as they did in 1997.

Prostate cancer risk linked to family history of breast, upper GI cancer

A new study shows that a family history of other cancers in first-degree relatives may increase a patient's risk for prostate cancer, according to findings presented at the American Urological Association 2011 Annual Meeting.

Urological association at odds with new prostate recommendations

The American Urological Association and the American Cancer Society disagree over when baseline screening should begin.

Sign Up for Free e-newsletters